Potential pharmacy closure might benefit another pharmacist
Graham Phillips’s excellent and passionate letter about the future of his Southdown, Harpenden, Hertfordshire pharmacy (Electronicjuice 2016;297:294) illustrates the quandary proprietor pharmacists have.
Before I retired, I had a small chain of pharmacies that were arbitrarily classified as independent but, in fact, were small multiples with few of the advantages (e.g. little economy of scale, less sophisticated IT) compared with our larger multiple colleagues. However, as practising owners we can ensure our pharmacies are customer focused and pharmacy centred rather than system driven.
In Phillips’s case, even from the few facts he has given in his letter, one can deduce that the Southdown pharmacy is probably not contributing much to the balance sheet of his company, although it is undoubtedly an invaluable healthcare facility to his community.
The end of a lease gives the landlord and tenant the opportunity to decide whether to continue with the current tenancy. I am sure he has been considering his options for some months and, as he points out, the funding cuts have weighted the scales in favour of closure. However, if he closes he will gain nothing except perhaps some of the Southdown pharmacy prescriptions transferring to his other Harpenden pharmacy.
In my experience, a true independent — a pharmacist proprietor manager — would be able to improve the viability of a discarded branch of a multiple. There are many newly registered pharmacists waiting for an opportunity to own their own pharmacy, but goodwill prices are often prohibitive.
Perhaps Phillips now has the chance to give such a person a wonderful opportunity and any nominal goodwill funds he achieves would be a bonus to his company.
Citation: Electronicjuice DOI: 10.1211/PJ.2016.20202022
Recommended from Pharmaceutical Press
Over 90 case studies based on real life patient-care scenarios. Each case includes learning outcomes and references.£47.00
A complete source of current information about the US health care system. Includes concise reports on trends, regulations, policy and finances.£49.00
Written for new pharmaceutical scientists, this book provides a background in paediatric pharmacy and a comprehensive introduction to children's medication.£33.00
This established textbook covers every aspect of drug properties from the design of dosage forms to their delivery by all routes to sites of action in the body.£48.00
An A-Z pocket book containing concise and practical pharmaceutical information for busy clinical pharmacists.£33.00